• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肝癌:连接细胞研究和流行病学与代谢组学的联系。

Primary Liver Cancers: Connecting the Dots of Cellular Studies and Epidemiology with Metabolomics.

机构信息

Faculty of Agricultural Sciences and Landscape Architecture, Osnabrueck University of Applied Sciences, Am Kruempel 31, 49090 Osnabrueck, Germany.

出版信息

Int J Mol Sci. 2023 Jan 26;24(3):2409. doi: 10.3390/ijms24032409.

DOI:10.3390/ijms24032409
PMID:36768732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9916415/
Abstract

Liver cancers are rising worldwide. Between molecular and epidemiological studies, a research gap has emerged which might be amenable to the technique of metabolomics. This review investigates the current understanding of liver cancer's trends, etiology and its correlates with existing literature for hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA) and hepatoblastoma (HB). Among additional factors, the literature reports dysfunction in the tricarboxylic acid metabolism, primarily for HB and HCC, and point mutations and signaling for CCA. All cases require further investigation of upstream and downstream events. All liver cancers reported dysfunction in the WNT/β-catenin and P13K/AKT/mTOR pathways as well as changes in FGFR. Metabolites of IHD1, IDH2, miRNA, purine, Q10, lipids, phosphatidylcholine, phosphatidylethanolamine, acylcarnitine, 2-HG and propionyl-CoA emerged as crucial and there was an attempt to elucidate the WNT/β-catenin and P13K/AKT/mTOR pathways metabolomically.

摘要

肝癌在全球范围内呈上升趋势。在分子和流行病学研究之间,出现了一个研究空白,可能适合代谢组学技术。本综述调查了肝癌趋势、病因及其与肝细胞癌 (HCC)、胆管细胞癌 (CCA) 和肝母细胞瘤 (HB) 现有文献的相关性的当前理解。在其他因素中,文献报告三羧酸代谢功能障碍,主要是针对 HB 和 HCC,以及 CCA 的点突变和信号传导。所有病例都需要进一步调查上游和下游事件。所有报告的肝癌在 WNT/β-catenin 和 P13K/AKT/mTOR 途径以及 FGFR 变化方面均存在功能障碍。IHD1、IDH2、miRNA、嘌呤、Q10、脂质、磷脂酰胆碱、磷脂酰乙醇胺、酰基辅酶 A、2-HG 和丙酰辅酶 A 的代谢物成为关键,并且试图从代谢组学角度阐明 WNT/β-catenin 和 P13K/AKT/mTOR 途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0014/9916415/b5ac06b951a3/ijms-24-02409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0014/9916415/bd5972d3864a/ijms-24-02409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0014/9916415/b5ac06b951a3/ijms-24-02409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0014/9916415/bd5972d3864a/ijms-24-02409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0014/9916415/b5ac06b951a3/ijms-24-02409-g002.jpg

相似文献

1
Primary Liver Cancers: Connecting the Dots of Cellular Studies and Epidemiology with Metabolomics.原发性肝癌:连接细胞研究和流行病学与代谢组学的联系。
Int J Mol Sci. 2023 Jan 26;24(3):2409. doi: 10.3390/ijms24032409.
2
Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.Wnt/β-catenin 信号通路作为胆管癌潜在的关键药理学靶点。
Biosci Rep. 2020 Mar 27;40(3). doi: 10.1042/BSR20193353.
3
Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosis.在肝细胞癌和胆管细胞癌合并癌中 Akt/哺乳动物雷帕霉素靶蛋白通路的激活:胆管细胞癌成分中 p-4E-BP1 表达与预后的显著相关性。
Virchows Arch. 2020 Jun;476(6):881-890. doi: 10.1007/s00428-019-02741-3. Epub 2020 Jan 11.
4
Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.β-连环蛋白和 Yap1 在人肝癌中的激活及在小鼠中诱导肝癌发生。
Gastroenterology. 2014 Sep;147(3):690-701. doi: 10.1053/j.gastro.2014.05.004. Epub 2014 May 14.
5
Oncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.维甲酸受体 γ 的致癌活性通过胆管癌细胞中 Akt/NF-κB 和 Wnt/β-连环蛋白通路的激活来表现。
Mol Cell Biol. 2013 Sep;33(17):3416-25. doi: 10.1128/MCB.00384-13. Epub 2013 Jun 24.
6
Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model.华支睾吸虫感染在胆管癌发生模型中激活PI3K/AKT/PTEN和Wnt/β-连环蛋白信号通路。
Asian Pac J Cancer Prev. 2014;15(23):10463-8. doi: 10.7314/apjcp.2014.15.23.10463.
7
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.针对 Akt/β-catenin 驱动的肝癌中 SP/CD44+致瘤细胞的 Jak/Stat 通路作为一种治疗策略。
J Hepatol. 2020 Jan;72(1):104-118. doi: 10.1016/j.jhep.2019.08.035. Epub 2019 Sep 18.
8
WNT/β-catenin signaling in the development of liver cancers.WNT/β-catenin 信号通路在肝癌发生发展中的作用。
Biomed Pharmacother. 2020 Dec;132:110851. doi: 10.1016/j.biopha.2020.110851. Epub 2020 Oct 17.
9
Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.联合使用 MK-2206 和 RAD001 靶向 AKT 和 mTOR 可协同治疗胆管癌。
Int J Cancer. 2013 Nov;133(9):2065-76. doi: 10.1002/ijc.28214. Epub 2013 May 29.
10
Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.PI3K/AKT信号通路的激活增加与胆管癌转移相关,PI3K/mTOR抑制是一种可能的治疗策略。
Tumour Biol. 2013 Dec;34(6):3637-48. doi: 10.1007/s13277-013-0945-2. Epub 2013 Jul 6.

引用本文的文献

1
Hepatitis B virus core protein promotes liver cancer progression by stabilizing CANX and suppressing IRF7 transcription.乙肝病毒核心蛋白通过稳定钙网蛋白并抑制干扰素调节因子7转录来促进肝癌进展。
Acta Pharmacol Sin. 2025 Jun 13. doi: 10.1038/s41401-025-01586-8.
2
Lipid Metabolism Reprogramming in Tumor-Associated Macrophages Modulates Their Function in Primary Liver Cancers.肿瘤相关巨噬细胞中的脂质代谢重编程调节其在原发性肝癌中的功能。
Cancers (Basel). 2025 May 31;17(11):1858. doi: 10.3390/cancers17111858.
3
Hepatoblastoma: From Molecular Mechanisms to Therapeutic Strategies.

本文引用的文献

1
Microbiome and Metabolomics in Liver Cancer: Scientific Technology.肝癌的微生物组学和代谢组学:科学技术。
Int J Mol Sci. 2022 Dec 28;24(1):537. doi: 10.3390/ijms24010537.
2
Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview.通过生物活性天然产物靶向Ras-ERK级联反应用于癌症的潜在治疗:最新综述
Cancer Cell Int. 2022 Aug 8;22(1):246. doi: 10.1186/s12935-022-02666-z.
3
RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state.
肝母细胞瘤:从分子机制到治疗策略
Curr Oncol. 2025 Mar 4;32(3):149. doi: 10.3390/curroncol32030149.
4
Bidirectional regulation of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon gene pathway and its impact on hepatocellular carcinoma.环磷酸鸟苷-磷酸腺苷合酶-干扰素基因刺激因子通路的双向调控及其对肝细胞癌的影响
World J Gastrointest Oncol. 2025 Feb 15;17(2):98556. doi: 10.4251/wjgo.v17.i2.98556.
5
Identification of novel M2 macrophage-related molecule ATP6V1E1 and its biological role in hepatocellular carcinoma based on machine learning algorithms.基于机器学习算法鉴定新型 M2 巨噬细胞相关分子 ATP6V1E1 及其在肝细胞癌中的生物学作用。
J Cell Mol Med. 2024 Sep;28(18):e70072. doi: 10.1111/jcmm.70072.
6
Identifying Proteins and Amino Acids Associated with Liver Cancer Risk: A Study Utilizing Mendelian Randomization and Bulk RNA Sequencing Analysis.鉴定与肝癌风险相关的蛋白质和氨基酸:一项利用孟德尔随机化和批量RNA测序分析的研究
J Pers Med. 2024 Feb 28;14(3):262. doi: 10.3390/jpm14030262.
7
Transarterial Radioembolization for Management of Hepatocellular Carcinoma.经动脉放射栓塞治疗肝细胞癌。
Oncologist. 2024 Feb 2;29(2):117-122. doi: 10.1093/oncolo/oyad327.
RNF43/ZNRF3 缺失通过损害肝脏再生和改变肝脏脂质代谢基础状态而导致肝细胞癌的发生。
Nat Commun. 2022 Jan 17;13(1):334. doi: 10.1038/s41467-021-27923-z.
4
The RSPO-LGR4/5-ZNRF3/RNF43 module in liver homeostasis, regeneration, and disease.RSPO-LGR4/5-ZNRF3/RNF43 模块在肝脏稳态、再生和疾病中的作用。
Hepatology. 2022 Sep;76(3):888-899. doi: 10.1002/hep.32328. Epub 2022 Feb 20.
5
Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma.ETS1/miR-23a-3p/ACSL4 轴通过表观遗传调控介导索拉非尼耐药在人肝癌中的作用。
J Exp Clin Cancer Res. 2022 Jan 3;41(1):3. doi: 10.1186/s13046-021-02208-x.
6
Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-β.工程化肿瘤抗原特异性 T 细胞以克服 TGF-β 的免疫抑制作用。
J Immunol. 2022 Jan 1;208(1):169-180. doi: 10.4049/jimmunol.2001357. Epub 2021 Dec 1.
7
An Epigenetic Switch Between Differentiation and Proliferation in Hepatoblastoma.肝母细胞瘤中分化与增殖之间的表观遗传开关
Cell Mol Gastroenterol Hepatol. 2021;12(5):1875-1876. doi: 10.1016/j.jcmgh.2021.08.020. Epub 2021 Sep 15.
8
Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma.肝细胞癌中的线粒体代谢特征。
Cells. 2021 Jul 27;10(8):1901. doi: 10.3390/cells10081901.
9
Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma.葡萄糖剥夺诱导的异常 FUT1 介导的岩藻糖基化驱动肝癌中的癌症干性。
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI143377.
10
Molecular Mechanisms of Hepatoblastoma.肝癌的分子机制。
Semin Liver Dis. 2021 Jan;41(1):28-41. doi: 10.1055/s-0040-1722645. Epub 2021 Jan 20.